期刊
EUROPEAN NEUROLOGY
卷 58, 期 4, 页码 228-232出版社
KARGER
DOI: 10.1159/000107945
关键词
interferon-inducible; T-cell alpha-chemoattractant; Interleukin-18; multiple sclerosis; methylprednisolone
Background/Aims: Chemokines may play a role in the pathogenesis of multiple sclerosis ( MS), facilitating the trafficking of immune cells across the blood-brain barrier. Interferon-inducible T-cell alpha-chemoattractant (CXCL11) recruits activated Th1 cells to sites of inflammation. In this study, we wanted to estimate the levels of CXCL11 chemokine and interleukin-18 (IL-18), a proinflammatory cytokine, in sera of relapsing-remitting MS (RRMS) patients, both before and after methylprednisolone ( MP) treatment, and to compare the results with those in the control group. Materials and Methods: Serum CXCL11 and IL-18 concentrations were measured by the ELISA method in 30 RRMS patients during relapse both before and after MP treatment, and in 20 healthy blood donors. Results: We found significantly increased CXCL11 and IL-18 serum levels in RRMS patients as compared with controls. Additionally, no influence of MP therapy on the serum levels of CXCL11 and IL-18 was observed. Conclusion: We suggest that CXCR3 receptor ligand, CXCL11, may be involved in MS pathogenesis. Copyright (c) 2007 S. Karger AG, Basel.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据